Update in Critical Care for the Nephrologist: Transfusion in Nonhemorrhaging Critically Ill Patients

Advances in Chronic Kidney Disease

Volumn 20, Issue 1, 2013, Pages 30-38

  Afshar, Majid ^a   Netzer, Giora ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Blood transfusion; Critically ill; Fresh frozen plasma; Platelets; Red blood cells

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; IRON;

ACUTE CORONARY SYNDROME; ANEMIA; ANTICOAGULATION; BLEEDING; BLOOD BANK; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CORONARY ARTERY DISEASE; CRITICALLY ILL PATIENT; ERYTHROCYTE TRANSFUSION; GLOMERULUS FILTRATION RATE; HUMAN; INTENSIVE CARE; NEPHROLOGIST; PATHOPHYSIOLOGY; PHLEBOTOMY; PLASMA TRANSFUSION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

ANEMIA; BLOOD PRESERVATION; BLOOD TRANSFUSION; CRITICAL CARE; CRITICAL ILLNESS; ERYTHROCYTES; HUMANS; NEPHROLOGY; PRACTICE GUIDELINES AS TOPIC; RENAL INSUFFICIENCY, CHRONIC;

EID: 84871588835     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2012.10.007     Document Type: Review

References (123)

1. Bagshaw S.M., Mortis G., Doig C.J., Godinez-Luna T., Fick G.H., Laupland K.B. One-year mortality in critically ill patients by severity of kidney dysfunction: A population-based assessment. Am J Kidney Dis 2006, 48:402-409.
2. Bell M., Granath F., Schon S., Lofberg E., Ekbom A., Martling C.R. End-stage renal disease patients on renal replacement therapy in the intensive care unit: Short- and long-term outcome. Crit Care Med 2008, 36:2773-2778.
3. Clermont G., Acker C.G., Angus D.C., Sirio C.A., Pinsky M.R., Johnson J.P. Renal failure in the ICU: Comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 2002, 62:986-996.
4. Hutchison C.A., Crowe A.V., Stevens P.E., Harrison D.A., Lipkin G.W. Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: A secondary analysis of the ICNARC Case Mix Programme Database. Crit Care 2007, 11:R50.
5. Warnock D.G., McClellan W., McClure L.A., et al. Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: Baseline results. Kidney Int 2005, 68:1427-1431.
6. De Nicola L., Minutolo R., Chiodini P., et al. Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: A prospective cohort study in outpatient renal clinics. Am J Nephrol 2010, 32:533-540.
7. Vincent J.L., Baron J.F., Reinhart K., et al. Anemia and blood transfusion in critically ill patients. JAMA 2002, 288:1499-1507.
8. Corwin H.L., Gettinger A., Pearl R.G., et al. The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004, 32:39-52.
9. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 2006, 47(suppl 3):S11-S145.
10. Nguyen B.V., Bota D.P., Melot C., Vincent J.L. Time course of hemoglobin concentrations in nonbleeding intensive care unit patients. Crit Care Med 2003, 31:406-410.
11. von Ahsen N., Muller C., Serke S., Frei U., Eckardt K.U. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 1999, 27:2630-2639.
12. Hadfield R.J., Sinclair D.G., Houldsworth P.E., Evans T.W. Effects of enteral and parenteral nutrition on gut mucosal permeability in the critically ill. Am J Respir Crit Care Med 1995, 152:1545-1548.
13. Cook D., Heyland D., Griffith L., Cook R., Marshall J., Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med 1999, 27:2812-2817.
14. Frede S., Fandrey J., Pagel H., Hellwig T., Jelkmann W. Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats. Am J Physiol 1997, 273:R1067-R1071.
15. Jelkmann W.E., Fandrey J., Frede S., Pagel H. Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states. Ann N Y Acad Sci 1994, 718:300-309. discussion 309-311.
16. Johnson C.S., Cook C.A., Furmanski P. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNF-alpha): Reversal with exogenous erythropoietin (EPO). Exp Hematol 1990, 18:109-113.
17. Pieracci F.M., Barie P.S. Diagnosis and management of iron-related anemias in critical illness. Crit Care Med 2006, 34:1898-1905.
18. Rodriguez R.M., Corwin H.L., Gettinger A., Corwin M.J., Gubler D., Pearl R.G. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J Crit Care 2001, 16:36-41.
19. Hebert P.C., Fergusson D., Blajchman M.A., et al. Clinical outcomes following institution of the canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003, 289:1941-1949.
20. Shapiro M.J. To filter blood or universal leukoreduction: What is the answer?. Crit Care 2004, 8(suppl 2):S27-S30.
21. Whillier S., Raftos J.E., Sparrow R.L., Kuchel P.W. The effects of long-term storage of human red blood cells on the glutathione synthesis rate and steady-state concentration. Transfusion 2011, 51:1450-1459.
22. Hess J.R. Red cell changes during storage. Transfus Apher Sci 2010, 43:51-59.
23. Hess J.R., Greenwalt T.G. Storage of red blood cells: New approaches. Transfus Med Rev 2002, 16:283-295.
24. Hall T.L., Barnes A., Miller J.R., Bethencourt D.M., Nestor L. Neonatal mortality following transfusion of red cells with high plasma potassium levels. Transfusion 1993, 33:606-609.
25. Koch C.G., Li L., Sessler D.I., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008, 358:1229-1239.
26. Kor D.J., Kashyap R., Weiskopf R.B., et al. Fresh red blood cell transfusion and short-term pulmonary, immunologic, and coagulation status: A randomized clinical trial. Am J Respir Crit Care Med 2012, 185:842-850.
27. Walsh T.S., McArdle F., McLellan S.A., et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients?. Crit Care Med 2004, 32:364-371.
28. Zimrin A.B., Hess J.R. Current issues relating to the transfusion of stored red blood cells. Vox Sang 2009, 96:93-103.
29. Steiner M.E., Assmann S.F., Levy J.H., et al. Addressing the question of the effect of RBC storage on clinical outcomes: The Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci 2010, 43:107-116.
30. Tinmouth A., Fergusson D., Yee I.C., Hebert P.C. Clinical consequences of red cell storage in the critically ill. Transfusion 2006, 46:2014-2027.
31. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417.
32. Hebert P.C., Blajchman M.A., Cook D.J., et al. Do blood transfusions improve outcomes related to mechanical ventilation?. Chest 2001, 119:1850-1857.
33. Lacroix J., Hebert P.C., Hutchison J.S., et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007, 356:1609-1619.
34. Carson J.L., Carless P.A., Hebert P.C. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2012, 4:CD002042.
35. Carson J.L., Grossman B.J., Kleinman S., et al. Red blood cell transfusion: A clinical practice guideline from the AABB. Ann Intern Med 2012, 157:49-58.
36. Foley R.N., Parfrey P.S. Cardiac disease in chronic uremia: Clinical outcome and risk factors. Adv Ren Replace Ther 1997, 4:234-248.
37. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
38. Carson J.L., Terrin M.L., Noveck H., et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011, 365:2453-2462.
39. Hebert P.C., Yetisir E., Martin C., et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?. Crit Care Med 2001, 29:227-234.
40. Sabatine M.S., Morrow D.A., Giugliano R.P., et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005, 111:2042-2049.
41. Alexander K.P., Chen A.Y., Wang T.Y., et al. Transfusion practice and outcomes in non-st-segment elevation acute coronary syndromes. Am Heart J 2008, 155:1047-1053.
42. Rao S.V., Jollis J.G., Harrington R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004, 292:1555-1562.
43. Wu W.C., Rathore S.S., Wang Y., Radford M.J., Krumholz H.M. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001, 345:1230-1236.
44. Garfinkle M., Lawler P.R., Filion K.B., Eisenberg M.J. Red blood cell transfusion and mortality among patients hospitalized for acute coronary syndromes: A systematic review. Int J Cardiol 2012.
45. Napolitano L.M., Kurek S., Luchette F.A., et al. Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care*. Crit Care Med 2009, 37:3124-3157.
46. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
47. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
48. Boyd O., Grounds R.M., Bennett E.D. A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993, 270:2699-2707.
49. Shoemaker W.C., Appel P.L., Kram H.B. Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients. Chest 1992, 102:208-215.
50. Archie J.P. Mathematic coupling of data: A common source of error. Ann Surg 1981, 193:296-303.
51. Phang P.T., Cunningham K.F., Ronco J.J., Wiggs B.R., Russell J.A. Mathematical coupling explains dependence of oxygen consumption on oxygen delivery in ARDS. Am J Respir Crit Care Med 1994, 150:318-323.
52. Shoemaker W.C., Appel P.L., Kram H.B., Waxman K., Lee T.S. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988, 94:1176-1186.
53. Hanique G., Dugernier T., Laterre P.F., Dougnac A., Roeseler J., Reynaert M.S. Significance of pathologic oxygen supply dependency in critically ill patients: Comparison between measured and calculated methods. Intensive Care Med 1994, 20:12-18.
54. Netzer G., Dutton R.P., Hess J.R. Light from the EAST-SCCM. Crit Care Med 2009, 37:3184-3185.
55. Annat G., Viale J.P., Percival C., Froment M., Motin J. Oxygen delivery and uptake in the adult respiratory distress syndrome. Lack of relationship when measured independently in patients with normal blood lactate concentrations. Am Rev Respir Dis 1986, 133:999-1001.
56. Mohsenifar Z., Ross D.J. Oxygen consumption is independent of changes in oxygen delivery in severe adult respiratory distress syndrome. Am Rev Respir Dis 1992, 145:978-979.
57. Alia I., Esteban A., Gordo F., et al. A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest 1999, 115:453-461.
58. Fernandes C.J., Akamine N., De Marco F.V., De Souza J.A., Lagudis S., Knobel E. Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care 2001, 5:362-367.
59. Silverman H.J., Tuma P. Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions. Chest 1992, 102:184-188.
60. Marik P.E., Sibbald W.J. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993, 269:3024-3029.
61. Sakr Y., Chierego M., Piagnerelli M., et al. Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med 2007, 35:1639-1644.
62. Napolitano L.M., Kurek S., Luchette F.A., et al. Clinical practice guideline: Red blood cell transfusion in adult trauma and critical care. J Trauma 2009, 67:1439-1442.
63. Miller Y., Bachowski G., Benjamin R., et al. Practice Guidelines for Blood Transfusion: A Compilation from Recent Peer-Reviewed Literatures 2007, American Red Cross, Washington, DC. 2nd ed.
64. Practice guidelines for perioperative blood transfusion and adjuvant therapies: An updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006, 105:198-208.
65. Slichter S.J., Kaufman R.M., Assmann S.F., et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010, 362:600-613.
66. Heal J.M., Masel D., Rowe J.M., Blumberg N. Circulating immune complexes involving the ABO system after platelet transfusion. Br J Haematol 1993, 85:566-572.
67. Slichter S.J. Evidence-based platelet transfusion guidelines. Hematol Am Soc Hematol Educ Program 2007, 172-178.
68. Greeno E., McCullough J., Weisdorf D. Platelet utilization and the transfusion trigger: A prospective analysis. Transfusion 2007, 47:201-205.
69. Slichter S.J. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 2004, 18:153-167.
70. Diedrich B., Remberger M., Shanwell A., Svahn B.M., Ringden O. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients. Transfusion 2005, 45:1064-1072.
71. Netzer G., Dutton R.P., Hess J.R. Blood transfusion in critical care. F1000 Med Rep 2009, 1.
72. Samama C.M., Djoudi R., Lecompte T., Nathan-Denizot N., Schved J.F. Perioperative platelet transfusion: Recommendations of the Agence Francaise de Securite Sanitaire des Produits de Sante (AFSSaPS) 2003. Can J Anaesth 2005, 52:30-37.
73. Hess J.R., Lindell A.L., Stansbury L.G., Dutton R.P., Scalea T.M. The prevalence of abnormal results of conventional coagulation tests on admission to a trauma center. Transfusion 2009, 49:34-39.
74. Hess J.R., Brohi K., Dutton R.P., et al. The coagulopathy of trauma: A review of mechanisms. J Trauma 2008, 65:748-754.
75. Holcomb J.B., Wade C.E., Michalek J.E., et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg 2008, 248:447-458.
76. Holland L.L., Foster T.M., Marlar R.A., Brooks J.P. Fresh frozen plasma is ineffective for correcting minimally elevated international normalized ratios. Transfusion 2005, 45:1234-1235.
77. Abdel-Wahab O.I., Healy B., Dzik W.H. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities. Transfusion 2006, 46:1279-1285.
78. Ageno W., Gallus A.S., Wittkowsky A., Crowther M., Hylek E.M., Palareti G. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(2 suppl):e44S-e88S.
79. Roback J.D., Caldwell S., Carson J., et al. Evidence-based practice guidelines for plasma transfusion. Transfusion 2010, 50:1227-1239.
80. Vlaar A.P., Binnekade J.M., Prins D., et al. Risk factors and outcome of transfusion-related acute lung injury in the critically ill: A nested case-control study. Crit Care Med 2010, 38:771-778.
81. Murad M.H., Stubbs J.R., Gandhi M.J., et al. The effect of plasma transfusion on morbidity and mortality: A systematic review and meta-analysis. Transfusion 2010, 50:1370-1383.
82. O'Shaughnessy D.F., Atterbury C., Bolton Maggs P., et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004, 126:11-28.
83. Runyon B.A. Management of adult patients with ascites due to cirrhosis: An update. Hepatology 2009, 49:2087-2107.
84. Busch M.P., Kleinman S.H., Nemo G.J. Current and emerging infectious risks of blood transfusions. JAMA 2003, 289:959-962.
85. Toy P., Popovsky M.A., Abraham E., et al. Transfusion-related acute lung injury: Definition and review. Crit Care Med 2005, 33:721-726.
86. Goldman M., Webert K.E., Arnold D.M., Freedman J., Hannon J., Blajchman M.A. Proceedings of a consensus conference: Towards an understanding of TRALI. Transfus Med Rev 2005, 19:2-31.
87. Gajic O., Rana R., Winters J.L., et al. Transfusion-related Acute Lung Injury in the Critically Ill: Prospective Nested Case-Control Study. Am J Respir Crit Care Med 2007, 176:886-891.
88. Toy P., Gajic O., Bacchetti P., et al. Transfusion-related acute lung injury: Incidence and risk factors. Blood 2012, 119:1757-1767.
89. Opelz G., Sengar D.P., Mickey M.R., Terasaki P.I. Effect of blood transfusions on subsequent kidney transplants. Transpl Proc 1973, 5:253-259.
90. Biedler A.E., Schneider S.O., Seyfert U., et al. Impact of alloantigens and storage-associated factors on stimulated cytokine response in an in vitro model of blood transfusion. Anesthesiology 2002, 97:1102-1109.
91. Prins H.A., Houdijk A.P., Nijveldt R.J., et al. Arginase release from red blood cells: Possible link in transfusion induced immune suppression?. Shock 2001, 16:113-115.
92. Ghio M., Ottonello L., Contini P., et al. Transforming growth factor-beta1 in supernatants from stored red blood cells inhibits neutrophil locomotion. Blood 2003, 102:1100-1107.
93. Jensen L.S., Andersen A.J., Christiansen P.M., et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992, 79:513-516.
94. Vamvakas E.C., Blajchman M.A. Transfusion-related immunomodulation (TRIM): An update. Blood Rev 2007, 21:327-348.
95. Netzer G., Hess J.R. TRALI, transfusion, and acute lung injury: Synergy in action?. Crit Care Med 2010, 38:981-982.
96. Gajic O., Gropper M.A., Hubmayr R.D. Pulmonary edema after transfusion: How to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med 2006, 34(5 suppl):S109-S113.
97. Narick C., Triulzi D.J., Yazer M.H. Transfusion-associated circulatory overload after plasma transfusion. Transfusion 2012, 52:160-165.
98. Rana R., Fernandez-Perez E.R., Khan S.A., et al. Transfusion-related acute lung injury and pulmonary edema in critically ill patients: A retrospective study. Transfusion 2006, 46:1478-1483.
99. Tinmouth A., Macdougall L., Fergusson D., et al. Reducing the amount of blood transfused: A systematic review of behavioral interventions to change physicians' transfusion practices. Arch Intern Med 2005, 165:845-852.
100. Corwin H.L., Gettinger A., Rodriguez R.M., et al. Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Crit Care Med 1999, 27:2346-2350.
101. Corwin H.L., Gettinger A., Pearl R.G., et al. Efficacy of recombinant human erythropoietin in critically ill patients: A randomized controlled trial. JAMA 2002, 288:2827-2835.
102. Corwin H.L., Gettinger A., Fabian T.C., et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med 2007, 357:965-976.
103. D'Ambra M.N., Gray R.J., Hillman R., et al. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg 1997, 64:1686-1693.
104. Stowell C.P., Jones S.C., Enny C., Langholff W., Leitz G. An open-label, randomized, parallel-group study of perioperative epoetin alfa versus standard of care for blood conservation in major elective spinal surgery: Safety analysis. Spine (Phila Pa 1976) 2009, 34:2479-2485.
105. Najjar S.S., Rao S.V., Melloni C., et al. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: A randomized controlled trial. JAMA 2011, 305:1863-1872.
106. McCook O., Georgieff M., Scheuerle A., Moller P., Thiemermann C., Radermacher P. Erythropoietin in the critically ill: Do we ask the right questions?. Crit Care 2012, 16:319.
107. Moore E., Bellomo R. Erythropoietin (EPO) in acute kidney injury. Ann Intensive Care 2011, 1:3.
108. Song Y.R., Lee T., You S.J., et al. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: A pilot study. Am J Nephrol 2009, 30:253-260.
109. Endre Z.H., Walker R.J., Pickering J.W., et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010, 77:1020-1030.
110. Raghavan M., Marik P.E. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest 2005, 127:295-307.
111. Parkkinen J., von Bonsdorff L., Peltonen S., Gronhagen-Riska C., Rosenlof K. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. Nephrol Dial Transplant 2000, 15:1827-1834.
112. Pieracci F.M., Henderson P., Rodney J.R., et al. Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect (Larchmt) 2009, 10(1):9-19.
113. van Iperen C.E., Gaillard C.A., Kraaijenhagen R.J., Braam B.G., Marx J.J., van de Wiel A. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 2000, 28:2773-2778.
114. Foulke G.E., Harlow D.J. Effective measures for reducing blood loss from diagnostic laboratory tests in intensive care unit patients. Crit Care Med 1989, 17:1143-1145.
115. Prat G., Lefevre M., Nowak E., et al. Impact of clinical guidelines to improve appropriateness of laboratory tests and chest radiographs. Intensive Care Med 2009, 35:1047-1053.
116. Harber C.R., Sosnowski K.J., Hegde R.M. Highly conservative phlebotomy in adult intensive care-a prospective randomized controlled trial. Anaesth Intensive Care 2006, 34:434-437.
117. Low L.L., Harrington G.R., Stoltzfus D.P. The effect of arterial lines on blood-drawing practices and costs in intensive care units. Chest 1995, 108:216-219.
118. Toulon P., Ozier Y., Ankri A., Fleron M.H., Leroux G., Samama C.M. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study. Thromb Haemost 2009, 101:394-401.
119. Gorlinger K., Fries D., Dirkmann D., Weber C.F., Hanke A.A., Schochl H. Reduction of fresh frozen plasma requirements by perioperative point-of-care coagulation management with early calculated goal-directed therapy. Transfus Med Hemother 2012, 39:104-113.
120. Netzer G., Liu X., Harris A.D., et al. Transfusion practice in the intensive care unit: A 10-year analysis. Transfusion 2010, 50:2125-2134.
121. Yilmaz M., Keegan M.T., Iscimen R., et al. Toward the prevention of acute lung injury: Protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion. Crit Care Med 2007, 35:1660-1666. quiz 1667.
122. Zilberberg M.D., Shorr A.F. Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: A model simulation. BMC Health Serv Res 2007, 7:138.
123. Schiffer C.A., Anderson K.C., Bennett C.L., et al. Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001, 19:1519-1538.